Unipolar vs. Bipolar Hemostasis in Total Knee Arthroplasty: A Prospective Randomized Trial
Completed · Not applicable
Conditions studied: Knee Arthroplasty
In brief
The use of Aquamantys during total knee arthroplasty will reduce drain output and the necessity for blood transfusions.
Key facts
- Study ID
- NCT01003080
- Run by
- Montefiore Medical Center
- People needed
- 111
- Starts
- 2009-08-01
- Expected to finish
- 2010-04-01
- Last updated by the study team
- 2018-09-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Patient indicated for total knee arthroplasty
You may not qualify if…
- Patients undergoing revision total knee arthroplasty
- Patients with blood disorders
- Patients on chronic anti-thrombotic medication such as Coumadin
- Patients with a history of deep vein thrombosis
- Patients with a history of pulmonary embolism
Where it is running
- Jack D. Weiler Hospital-Division of Montefiore Medical Center — The Bronx, New York, United States
- Montefiore Medical Center — The Bronx, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.